COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu

Premature Coronary Atherosclerosis in Scleroderma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00372398
Recruitment Status : Completed
First Posted : September 6, 2006
Last Update Posted : September 16, 2010
Information provided by:
Tuen Mun Hospital

Brief Summary:
The purpose of this trial is to study the proportion of scleroderma patients who suffer from asymptomatic coronary atherosclerosis compared to healthy controls.

Condition or disease

Detailed Description:
Coronary calcium scores will be obtained from a group of patients with scleroderma and a group of controls. Comparison of the calcium scores will be made.

Layout table for study information
Study Type : Observational
Actual Enrollment : 28 participants
Observational Model: Case-Control
Time Perspective: Cross-Sectional
Official Title: Premature Coronary Atherosclerosis in Scleroderma: A Case Control Study
Study Start Date : October 2006
Actual Primary Completion Date : July 2010
Actual Study Completion Date : July 2010

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population
scleroderma patients

Inclusion Criteria:

  1. Age >= 18 years.
  2. Fulfillment of the American College of Rheumatology (ACR) criteria for the classification of scleroderma.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00372398

Layout table for location information
Hong Kong
Tuen Mun Hospital
Hong Kong, Hong Kong
Sponsors and Collaborators
Tuen Mun Hospital
Layout table for investigator information
Principal Investigator: CC Mok, MD FRCP Tuen Mun Hospital, Hong Kong
Layout table for additonal information
Responsible Party: CC Mok, Tuen Mun Hospital, Hong Kong Identifier: NCT00372398    
Other Study ID Numbers: NTWC/CREC/429/06
First Posted: September 6, 2006    Key Record Dates
Last Update Posted: September 16, 2010
Last Verified: September 2010
Keywords provided by Tuen Mun Hospital:
Additional relevant MeSH terms:
Layout table for MeSH terms
Coronary Artery Disease
Myocardial Ischemia
Scleroderma, Systemic
Scleroderma, Diffuse
Scleroderma, Localized
Arterial Occlusive Diseases
Vascular Diseases
Cardiovascular Diseases
Connective Tissue Diseases
Skin Diseases
Coronary Disease
Heart Diseases